Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Oncology Clinical Trial
Study Evaluating the Safety and Pharmacokinetics of JCAR017 in B-cell Non-Hodgkin Lymphoma (TRANSCEND-NHL-001)
Status: Enrolling, Phase I
Updated: 12/31/1969
Fred Hutchinson/University of Washington Cancer Consortium
2006
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Asthma Clinical Trial
A Study of the Safety and Pharmacokinetics of Levodopa Following Administration of CVT 301 (Levodopa Inhalation Powder) in Adults With Asthma
Status: Enrolling, Phase I
Updated: 3/14/2016
Clinical Research Facility
910
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Concurrent Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma
Status: Enrolling, Phase II
Updated: 2/2/2016
Allan Blair Cancer Centre
1268
mi
from 43215
Regina,
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
Status: Enrolling, Phase
Updated: 4/18/2018
Northwell Health Cancer Institute
492
mi
from 43215
Lake Success, NY
Click here to add this to my saved trials
Osteoarthritis Clinical Trial
Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a Total Knee, Hip or Shoulder Replacement
Status: Enrolling, Phase III
Updated: 12/31/1969
PMG Research, Inc. d/b/a PMG Research of Knoxville
266
mi
from 43215
Jefferson City, TN
Click here to add this to my saved trials
Osteoarthritis Clinical Trial
Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a Total Knee, Hip or Shoulder Replacement
Status: Enrolling, Phase III
Updated: 12/31/1969
Professional Research Nework of Kansas, LLC
785
mi
from 43215
Wichita, KS
Click here to add this to my saved trials
Pompe Disease Clinical Trial
First-In-Human Study to Evaluate Safety, Tolerability, and PK of Intravenous ATB200 Alone and When Co-Administered With Oral AT2221
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Lysosomal & Rare Disorders Research & Treatment Center (LDRTC)
314
mi
from 43215
Fairfax, VA
Click here to add this to my saved trials
Hyperphosphatemia Clinical Trial
An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Status: Enrolling, Phase II
Updated: 4/7/2016
Ardelyx Investigative Site 405
1017
mi
from 43215
Bellville, TX
Click here to add this to my saved trials
Hyperphosphatemia Clinical Trial
An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Status: Enrolling, Phase II
Updated: 4/7/2016
Ardelyx Investigative Site 417
537
mi
from 43215
Columbus, MS
Click here to add this to my saved trials
Hyperphosphatemia Clinical Trial
An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Status: Enrolling, Phase II
Updated: 4/7/2016
Ardelyx Investigative Site 410
967
mi
from 43215
Lauderdale Lakes, FL
Click here to add this to my saved trials
Hyperphosphatemia Clinical Trial
An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Status: Enrolling, Phase II
Updated: 4/7/2016
Ardelyx Investigative Site 106
999
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Hyperphosphatemia Clinical Trial
An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Status: Enrolling, Phase II
Updated: 4/7/2016
Ardelyx Investigative Site 426
372
mi
from 43215
Raleigh, NC
Click here to add this to my saved trials
Hyperphosphatemia Clinical Trial
An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Status: Enrolling, Phase II
Updated: 4/7/2016
Ardelyx Investigative Site 424
174
mi
from 43215
Roseville, MI
Click here to add this to my saved trials
Spinal Stenosis Clinical Trial
The Coflex®COMMUNITY Study: An Observational Study of Coflex® Interlaminar Technology
Status: Enrolling, Phase
Updated: 12/31/1969
OrthoTexas
907
mi
from 43215
Carrollton, TX
Click here to add this to my saved trials
Acquired Hemophilia A Clinical Trial
Post-Marketing Non-Interventional Safety Evaluation of Obizur in the Treatment of Bleeding Episodes for Patients With Acquired Hemophilia A
Status: Enrolling, Phase
Updated: 3/22/2018
University of Colorado Health
1154
mi
from 43215
Aurora, CO
Click here to add this to my saved trials
Attention Deficit Hyperactivity Disorder (ADHD) Clinical Trial
Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 1)
Status: Enrolling, Phase III
Updated: 7/13/2017
American Medical Research
267
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Phase I Study of Enadenotucirev and PD-1 Inhibitor in Subjects With Metastatic or Advanced Epithelial Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
City of Hope Comprehensive Cancer Center, 1500 E Duarte Str.
1955
mi
from 43215
Duarte, CA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Duvelisib and Venetoclax in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Indolent or Aggressive Non-Hodgkin Lymphoma, Who Have Not Previously Received a Bcl-2 or PI3K Inhibitor
Status: Enrolling, Phase I
Updated: 4/11/2016
Clinical Research Facility
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Testing the Effect of Adding Chronic Oral Azithromycin to Inhaled Tobramycin in People With CF
Status: Enrolling, Phase IV
Updated: 12/31/1969
Hershey Medical Center Pennsylvania State University
336
mi
from 43215
Hershey, PA
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Testing the Effect of Adding Chronic Oral Azithromycin to Inhaled Tobramycin in People With CF
Status: Enrolling, Phase IV
Updated: 12/31/1969
The Minnesota Cystic Fibrosis Center
624
mi
from 43215
Minneapolis, MN
Click here to add this to my saved trials
Thrombotic and Bleeding Events Clinical Trial
On-X Aortic Prosthetic Heart Valve Low Dose Warfarin Post Approval Clinical Registry Study
Status: Enrolling, Phase
Updated: 12/31/1969
Franciscan St. Francis
163
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
An Open-Label Study to Evaluate the Safety and Efficacy of Ublituximab in Combination With TGR-1202 for Patients Previously Enrolled in Protocol UTX-TGR-304
Status: Enrolling, Phase II
Updated: 12/31/1969
TG Therapeutics Investigational Trial Site
955
mi
from 43215
Boca Raton, FL
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
An Open-Label Study to Evaluate the Safety and Efficacy of Ublituximab in Combination With TGR-1202 for Patients Previously Enrolled in Protocol UTX-TGR-304
Status: Enrolling, Phase II
Updated: 12/31/1969
TG Therapeutics Investigational Trial Site
163
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator Phenotype
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Westchester
493
mi
from 43215
Harrison, NY
Click here to add this to my saved trials
Peripheral Arterial Disease Clinical Trial
Excellence In Peripheral Artery Disease Thrombin Receptor Antagonist Intervention In Claudication Evaluation (XLPAD-TRACE Trial)
Status: Enrolling, Phase IV
Updated: 12/31/1969
Atlanta Heart Specialists
429
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Her2 Positive Breast Cancer Clinical Trial
A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
UCLA Medical Center / David Geffen School of Medicine
1982
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Her2 Positive Breast Cancer Clinical Trial
A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Texas Oncology - San Antonio Medical Center Northeast
1138
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Systemic Lupus Erythematosus Clinical Trial
A Phase 2a of RSLV-132 in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling, Phase II
Updated: 12/31/1969
Northwell Health/ Division of Rheumatology
493
mi
from 43215
Great Neck, NY
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability
Status: Enrolling, Phase IV
Updated: 4/1/2016
Clinical Research Facility
353
mi
from 43215
Lancaster, PA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability
Status: Enrolling, Phase IV
Updated: 4/1/2016
Clinical Research Facility
174
mi
from 43215
St. Clair Shores, MI
Click here to add this to my saved trials
Genetic Testing Clinical Trial
Prospective Registry of Multiplex Testing (PROMPT)
Status: Enrolling, Phase
Updated: 12/31/1969
Memoral Sloan Kettering Monmouth
469
mi
from 43215
Middletown, NJ
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
Online Information and Support for Distance Caregivers
Status: Enrolling
Updated: 12/31/1969
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
129
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Diabetic Foot Ulcers Clinical Trial
A Study of Granexin Gel in the Treatment of Diabetic Foot Ulcer
Status: Enrolling, Phase III
Updated: 12/31/1969
Direct Helpers Research Center
987
mi
from 43215
Hialeah, FL
Click here to add this to my saved trials
Diabetic Foot Ulcers Clinical Trial
A Study of Granexin Gel in the Treatment of Diabetic Foot Ulcer
Status: Enrolling, Phase III
Updated: 12/31/1969
New Hope Podiatry Group, Inc.
1972
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Penn State Cancer Institute
335
mi
from 43215
Hershey, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
Clinical Research Facility
789
mi
from 43215
Brooksville, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
Clinical Research Facility
1943
mi
from 43215
Chino, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
Clinical Research Facility
393
mi
from 43215
Endwell, NY
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
Clinical Research Facility
927
mi
from 43215
Hurst, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
Clinical Research Facility
668
mi
from 43215
Jacksonville, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
Clinical Research Facility
1972
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
Clinical Research Facility
993
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
Clinical Research Facility
757
mi
from 43215
Port Orange, FL
Click here to add this to my saved trials
Hyperphosphatemia Clinical Trial
An Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Washington University School of Medicine St. Louis
397
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
Bacterial Infections Clinical Trial
Study Evaluate the PK Profile of Dalbavancin in Infants and Neonates Patients With Known or Suspected Bacterial Infection
Status: Enrolling, Phase I
Updated: 12/31/1969
Mary Birch Hospital for Women and Newborns
1951
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
Neurology Clinical Trial
Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biology in Participants With Relapsing Multiple Sclerosis (RMS) or Primary Progressive Multiple Sclerosis (PPMS)
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Alberta Hospital
1700
mi
from 43215
Edmonton,
Click here to add this to my saved trials
Neurology Clinical Trial
Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biology in Participants With Relapsing Multiple Sclerosis (RMS) or Primary Progressive Multiple Sclerosis (PPMS)
Status: Enrolling, Phase III
Updated: 12/31/1969
International MS Management Practice
478
mi
from 43215
New York, NY
Click here to add this to my saved trials
Chronic Pancreatitis Clinical Trial
A Dose Ranging Study Evaluating Efficacy and Safety of NI-03
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of Colorado-Div of Gastroenterology and Hepatology
1154
mi
from 43215
Aurora, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma or Relapsed or Refractory Richter Syndrome (MK-3475-170/KEYNOTE-170)
Status: Enrolling, Phase II
Updated: 9/11/2017
Clinical Research Facility
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma or Relapsed or Refractory Richter Syndrome (MK-3475-170/KEYNOTE-170)
Status: Enrolling, Phase II
Updated: 9/11/2017
Clinical Research Facility
6
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma or Relapsed or Refractory Richter Syndrome (MK-3475-170/KEYNOTE-170)
Status: Enrolling, Phase II
Updated: 9/11/2017
Clinical Research Facility
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma or Relapsed or Refractory Richter Syndrome (MK-3475-170/KEYNOTE-170)
Status: Enrolling, Phase II
Updated: 9/11/2017
Clinical Research Facility
335
mi
from 43215
Milwaukee, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma or Relapsed or Refractory Richter Syndrome (MK-3475-170/KEYNOTE-170)
Status: Enrolling, Phase II
Updated: 9/11/2017
Merck Sharp & Dohme
9459
mi
from 43215
North Ryde,
Click here to add this to my saved trials
Ovarian Neoplasms Clinical Trial
Efficacy and Safety Study of Pembrolizumab (MK-3475) in Women With Advanced Recurrent Ovarian Cancer (MK-3475-100/KEYNOTE-100)
Status: Enrolling, Phase II
Updated: 6/28/2016
Clinical Research Facility
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Ovarian Neoplasms Clinical Trial
Efficacy and Safety Study of Pembrolizumab (MK-3475) in Women With Advanced Recurrent Ovarian Cancer (MK-3475-100/KEYNOTE-100)
Status: Enrolling, Phase II
Updated: 6/28/2016
Clinical Research Facility
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Ovarian Neoplasms Clinical Trial
Efficacy and Safety Study of Pembrolizumab (MK-3475) in Women With Advanced Recurrent Ovarian Cancer (MK-3475-100/KEYNOTE-100)
Status: Enrolling, Phase II
Updated: 6/28/2016
Clinical Research Facility
335
mi
from 43215
Milwaukee, WI
Click here to add this to my saved trials
Ovarian Neoplasms Clinical Trial
Efficacy and Safety Study of Pembrolizumab (MK-3475) in Women With Advanced Recurrent Ovarian Cancer (MK-3475-100/KEYNOTE-100)
Status: Enrolling, Phase II
Updated: 6/28/2016
Clinical Research Facility
1963
mi
from 43215
Whittier, CA
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
The PROMISE Study: Duavee in Women With DCIS
Status: Enrolling, Phase II
Updated: 12/31/1969
Washington University St. Louis Siteman Cancer Center
397
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
Oncology Clinical Trial
An Open-Label, Dose-Escalation, Safety Study of INCAGN01876 in Subjects With Advanced or Metastatic Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Memorial Sloan Kettering Monmouth
470
mi
from 43215
Middletown, NJ
Click here to add this to my saved trials
Macular Edema Clinical Trial
A Study in Participants With Neovascular Age Related Macular Degeneration or Macular Edema Secondary To Retinal Vein Occlusion to Evaluate Usability of the Lucentis® Prefilled Syringe
Status: Enrolling, Phase III
Updated: 3/2/2016
Clinical Research Facility
501
mi
from 43215
Germantown, TN
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Pomalidomide for Lenalidomide for Relapsed or Refractory Multiple Myeloma Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
Inland Hematology Oncology Medical Group, Inc
1918
mi
from 43215
San Bernardino, CA
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Study of Nivolumab in Unresectable Advanced or Recurrent Esophageal Cancer
Status: Enrolling, Phase III
Updated: 5/22/2017
Georgetown University Medical Center
325
mi
from 43215
Washington DC,
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Optimal Sequencing of Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in First-Line NSCLC
Status: Enrolling, Phase II
Updated: 4/11/2018
NorthShore University HealthSystem
282
mi
from 43215
Evanston, IL
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Optimal Sequencing of Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in First-Line NSCLC
Status: Enrolling, Phase II
Updated: 4/11/2018
University of Oklahoma Health Sciences Center, Stephenson Cancer Center
848
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Optimal Sequencing of Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in First-Line NSCLC
Status: Enrolling, Phase II
Updated: 4/11/2018
Lexington Oncology/ Lexington Medical Center
426
mi
from 43215
West Columbia, SC
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy
Status: Enrolling, Phase
Updated: 12/31/1969
Karmanos Cancer Institute Harper Hosp. Invest. Pharmacy
164
mi
from 43215
Detroit, MI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy
Status: Enrolling, Phase
Updated: 12/31/1969
Norton Cancer Institute Norton Cancer Institute
188
mi
from 43215
Louisville, KY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy
Status: Enrolling, Phase
Updated: 12/31/1969
University of Pennsylvania Cancer Center University of Pen/Abr Canc ctr
414
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy
Status: Enrolling, Phase
Updated: 12/31/1969
Huntsman Cancer Institute Univ. of Utah Hematology Clinic
1510
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
Stroke, Acute Clinical Trial
Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin
Status: Enrolling, Phase IV
Updated: 12/31/1969
Centra Medical Group Stroobants Cardiovascular Center
273
mi
from 43215
Lynchburg, VA
Click here to add this to my saved trials
Stroke, Acute Clinical Trial
Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin
Status: Enrolling, Phase IV
Updated: 12/31/1969
Mercy Clinic Cardiology
406
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
Stroke, Acute Clinical Trial
Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin
Status: Enrolling, Phase IV
Updated: 12/31/1969
Sacred Heart
2052
mi
from 43215
Springfield, OR
Click here to add this to my saved trials
Thyroid Cancer Clinical Trial
A Phase 2 Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 mg Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile
Status: Enrolling, Phase II
Updated: 12/31/1969
Facility 1
162
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
Thyroid Cancer Clinical Trial
A Phase 2 Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 mg Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile
Status: Enrolling, Phase II
Updated: 12/31/1969
Facility # 1
2
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
Thyroid Cancer Clinical Trial
A Phase 2 Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 mg Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile
Status: Enrolling, Phase II
Updated: 12/31/1969
Facility # 1
328
mi
from 43215
Washington DC,
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling, Phase
Updated: 4/5/2018
Bon Secours Medical Group/ Saint Francis Hospital Cancer Center
358
mi
from 43215
Greenville, SC
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling, Phase
Updated: 4/5/2018
University of Washington, Department of Radiology, Division of Nuclear Medicine
2006
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling, Phase
Updated: 4/5/2018
Stony Brook Cancer Center
524
mi
from 43215
Stony Brook, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor
Status: Enrolling, Phase II
Updated: 8/4/2016
Algemeen Ziekenhuis Sint-Jan
3997
mi
from 43215
Bruges,
Click here to add this to my saved trials
Oncology Clinical Trial
Trial to Evaluate the Safety ofTalimogene Laherparepvec Injected Into Liver Tumors Alone and in Combination With Systemic Pembrolizumab
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Alpha1-antitrypsin Deficiency Clinical Trial
PH 3/4 GLASSIA SAFETY, IMMUNOGENICITY, AND BRONCHOALVEOLAR LAVAGE STUDY
Status: Enrolling, Phase III
Updated: 12/31/1969
Renovatio Clinical-Respiratory & Sleep Disorders Specialists
975
mi
from 43215
The Woodlands, TX
Click here to add this to my saved trials
NASOPHARYNGEAL CARCINOMA Clinical Trial
A Phase III Trial Evaluating Chemotherapy and Immunotherapy for Advanced Nasopharyngeal Carcinoma (NPC) Patients
Status: Enrolling, Phase III
Updated: 12/31/1969
UCSF HDF Comprehensive Cancer Center
2109
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
Thrombotic and Bleeding Events Clinical Trial
On-X Aortic Prosthetic Heart Valve Low Dose Warfarin Post Approval Clinical Registry Study
Status: Enrolling, Phase
Updated: 12/31/1969
Providence St. Vincent
2031
mi
from 43215
Portland, OR
Click here to add this to my saved trials
Gastroenterology Clinical Trial
OTIS Vedolizumab Pregnancy Exposure Registry
Status: Enrolling, Phase
Updated: 12/31/1969
277
mi
from 43215
Multiple Locations,
Click here to add this to my saved trials
Gastroenterology Clinical Trial
OTIS Vedolizumab Pregnancy Exposure Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
1951
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Exploratory Study Comparing ClearSight System 2D Map to Post Surgery Histopathological Analysis in Lumpectomy
Status: Enrolling
Updated: 3/27/2016
Kaplan Hospital
6077
mi
from 43215
Rehovot,
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
110
mi
from 43215
Akron, OH
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
436
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
1980
mi
from 43215
Bakersfield, CA
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
862
mi
from 43215
Bradenton, FL
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
831
mi
from 43215
Brandon, FL
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
482
mi
from 43215
Bronx, NY
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
1538
mi
from 43215
Butte, MT
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
362
mi
from 43215
Chattanooga, TN
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
1949
mi
from 43215
Chula Vista, CA
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
1518
mi
from 43215
Clinton, UT
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
426
mi
from 43215
Columbia, SC
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
1952
mi
from 43215
Covina, CA
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
910
mi
from 43215
Dallas, TX
Click here to add this to my saved trials